Physiomics (LON:PYC) Shares Down 7.6% – Here’s Why

Physiomics Plc (LON:PYC)’s share price dropped 7.6% during trading on Friday . The stock traded as low as GBX 0.44 ($0.01) and last traded at GBX 0.45 ($0.01). Approximately 39,380,105 shares were traded during trading, an increase of 454% from the average daily volume of 7,107,858 shares. The stock had previously closed at GBX 0.49 ($0.01).

Physiomics Stock Performance

The business has a 50 day moving average price of GBX 0.43 and a two-hundred day moving average price of GBX 0.64. The stock has a market cap of £921,181.35, a PE ratio of -1.01 and a beta of 1.69.

Physiomics (LON:PYC) last posted its quarterly earnings results on Thursday, March 6th. The company reported GBX (0.12) ($0.00) earnings per share (EPS) for the quarter. Physiomics had a negative return on equity of 127.68% and a negative net margin of 106.80%. As a group, research analysts anticipate that Physiomics Plc will post -0.13 earnings per share for the current year.

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software.